MedPath

Effect of N-Acetyl Cysteine on liver and kidney function tests after surgical bypass in obstructive jaundice patients

Phase 2
Conditions
Obstruction of bile duct.
Obstruction of bile duct
Registration Number
IRCT2016041016473N7
Lead Sponsor
Tabriz University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Age above 18 years and below 75; unable to treta with ERCP or radiologic intervention; common bile diameter over 10 mm; no indication for resection of obstructive jaundice (choledochal cyst or Whipple procedure); bilirubin level over 5 mg/dl
Exclusion criteria: possibility of surgical resection (Whipple procedure or bile duct tumor resection); any contraindication for acetylcysteine injection (e.g. asthma, bronchospasm, angioedema or known hypersensitivity); liver cirrhosis or need for liver transplant according to clinical or surgical findings for any reason; known renal failure or heart failure; need for mechanical ventilation before surgery, septic shock resistant to inotrope ( Systolic blood pressure less than 90) before surgery; preoperative biliary drainage by ERCP or radiologic intervention; liver enzymes (ALT, AST) greater than 10 times the normal; acute viral hepatitis or any history of drug toxicity; known liver disease such as autoimmune hepatitis; hemolysis cases

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath